Search Results

Everolimus Versus Paclitaxel DES Studied in COMPARE

January 16, 2010—Elvin Kedhi, MD, et al have published findings from the COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) trial in The Lancet (2010;375:201–209).

COMPARE Trial Supports Everolimus-Eluting DES Versus Paclitaxel-Eluting DES

January 8, 2010—Elvin Kedhi, MD, et al have published findings from the COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) trial online ahead of print in The Lancet.

Combined FFR and OCT Imaging Studied to Identify High-Risk Lesions in Patients With Diabetes

October 14, 2020—The COMBINE (OCT-FFR) study found that the use of fractional flow reserve (FFR) combined with optical coherence tomography (OCT) imaging can help improve the accuracy of high-risk lesion identification in patients with diabetes.

Onyx 1-Month OCT Study Investigates DAPT Duration in Complex Patients After Stent Implantation

May 24, 2018—Medtronic announced that clinical data from the independently run Onyx 1-Month OCT study were presented at EuroPCR 2018, held May 21-25 in Paris, France.

Study Compares DAPT Durations in STEMI Patients Receiving DES

November 1, 2017—Results from the DAPT STEMI were reported at TCT 2017, the 29th annual Transcatheter Cardiovascular Therapeutics scientific symposium being held October 30 to November 2 in Denver, Colorado.